Table 2.
Grade Quality of evidence of acupuncture plus drug therapy for cancer pain.
| Outcomes | Illustrative comparative risks∗ (95% CI) | Relative effect (95% CI) | Number of participants (studies) |
Quality of the evidence (GRADE) |
|
|---|---|---|---|---|---|
| Assumed risk Control | Corresponding risk Acupuncture plus analgesic | ||||
| Response rate for relieving pain pain scale Follow-up: 7–30 days |
772 per 1000 816 per 1000 |
Study population 911 per 1000 (841 to 980) Moderate 963 per 1000 (889 to 1000) |
RR 1.18 (1.09 to 1.27) | 845 (11 studies) | ⊕ ⊝ ⊝ ⊝ Very low1,4 |
|
| |||||
| Onset time of pain relief Follow-up: 7–28 days |
The mean onset time of pain relief in the intervention groups was 1.06 standard deviations lower (1.34 to 0.79 lower) |
230 (4 studies) | ⊕ ⊝ ⊝ ⊝ Very low1,2,3 |
||
|
| |||||
| Duration of pain relief Follow-up: 7–28 days |
The mean duration of pain relief in the intervention groups was 1.03 standard deviations higher (0.49 to 1.57 higher) |
268 (5 studies) | ⊕ ⊝ ⊝ ⊝ Very low1,2,3,4 |
||
|
| |||||
| QOL Follow-up: 7–30 days |
The mean score of QOLl in the intervention groups was 1.44 standard deviations higher (0.43 to 2.44 higher) |
196 (3 studies) | ⊕ ⊝ ⊝ ⊝ Very low1,2,3,4 |
||
1None of the trials were blinded; most of them did not mention randomization process and allocation concealment.
2Total sample size is less than calculated optimal information size.
3Published evidence is limited to a small number of trials, all of which are showing benefits.
4Confidence intervals with minimal overlap, the heterogeneity is significant.
The GRADE profile noted “∗” means the basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).